INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 436m ago
HOUSE PTR36m ago
SEC 13F36m ago
ROBINHOOD CHAIN36m ago
Public company

MPLTMapLight Therapeutics, Inc.

CIK 0001770069

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 48
Max Insider Score43
Connections13with evidence

MPLT · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$124K
15.4K sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Luneborg Nanna LiebachDirector · Jun 25, 2026
  • ← Insider ofevidence
    Walker Maria CDirector · Jun 25, 2026
  • ← Insider ofevidence
    Cox TroyDirector · Jun 25, 2026
36
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL
$73K
9,020 sh
Oct 15, 2026
Oct 16, 2026
traded Oct 15, 2026
+1d
SEC FORM 4

Evidence

43
LW
Lillie James WoodruffChief Scientific Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$93K
11.5K sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

39
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$96K
12.2K sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

5
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
16.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

2
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
54.2K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC FORM 4

Evidence

5
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
24.5K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC FORM 4

Evidence

2
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
13.4K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC FORM 4

Evidence

5
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
6,020 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC FORM 4

Evidence

5
GJ
Garnett Timothy JohnDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
14.9K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
CT
Cox TroyDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
7,864 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
WC
Walker Maria CDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
14.9K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

13
WC
Walker Maria CDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
3,932 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
LL
Luneborg Nanna LiebachDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
14.9K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
GJ
Garnett Timothy JohnDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
3,932 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
LL
Luneborg Nanna LiebachDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
3,932 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

9
CT
Cox TroyDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
29.8K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC FORM 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
6,979 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
4,321 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC FORM 4

Evidence

13
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,405
117 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC FORM 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$177K
5,808 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

13
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
846 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

13
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$7,841
284 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,223
312 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

22
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$254K
8,989 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,607
325 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
787 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$279K
9,935 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

13
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
968 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
8,496 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

16
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
2,068 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

22
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$252K
9,180 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$155K
5,460 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
700 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$271K
9,645 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
8,152 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$463K
15.9K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

19
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$248K
9,030 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

19
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
3,908 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$8,750
296 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
683 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

13
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
931 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

19
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
4,803 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

30
GJ
Gillis JonathanCAAO and PAO
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$877K
29.6K sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

16
GJ
Gillis JonathanCAAO and PAO
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
700 sh
Apr 28, 2026Apr 29, 2026
traded Apr 28, 2026
+1dSEC FORM 4

Evidence

26
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$867K
29.3K sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

30
GJ
Gillis JonathanCAAO and PAO
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$437K
14.4K sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

19
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$242K
8,346 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

23
GJ
Gillis JonathanCAAO and PAO
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
7,914 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

26
GJ
Gillis JonathanCAAO and PAO
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$523K
17.2K sh
Apr 28, 2026Apr 29, 2026
traded Apr 28, 2026
+1dSEC FORM 4

Evidence

19
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$239K
7,821 sh
Apr 27, 2026Apr 29, 2026
traded Apr 27, 2026
+2dSEC FORM 4

Evidence

39
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$55K
2,044 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC FORM 4

Evidence

32
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$6,185
225 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

32
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$24K
881 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

32
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$2,392
87 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

32
SV
Setia VishwasChief Financial Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$783
29 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

32
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$1,972
73 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

16
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$231K
8,593 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC FORM 4

Evidence

36
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$41K
1,529 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC FORM 4

Evidence

32
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$7,779
288 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

← Insider ofevidence
Garnett Timothy John
Director · Feb 12, 2026
  • ← Insider ofevidence
    Malenka Robert C.Director · Jan 30, 2026
  • ← Insider ofevidence
    Hanson KristopherGeneral Counsel · Jan 29, 2026
  • ← Insider ofevidence
    Foff Erin PennockChief Medical Officer · Jan 29, 2026
  • ← Insider ofevidence
    Setia VishwasChief Financial Officer · Jan 29, 2026
  • ← Insider ofevidence
    Gillis JonathanCAAO and PAO · Jan 29, 2026
  • ← Insider ofevidence
    Lillie James WoodruffChief Scientific Officer · Jan 29, 2026
  • ← Insider ofevidence
    Kreitzer AnatolChief Discovery Officer · Jan 29, 2026
  • ← Insider ofevidence
    Kroeger Christopher A.Director, Chief Executive Officer · Jan 29, 2026